WA
IDXX icon

Waverly Advisors’s Idexx Laboratories IDXX Stock Holding History

Waverly Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Sell
2,995
-173
-5% -$97K 0.01% 756
2026
Q1 		$1.78M Buy
3,168
+144
+5% +$92.3K 0.01% 670
2025
Q4 		$2.05M Buy
3,024
+2,343
+344% +$1.6M 0.02% 594
2025
Q3 		$435K Sell
681
-6
-0.9% -$3.64K ﹤0.01% 900
2025
Q2 		$368K Sell
687
-43
-6% -$20.6K ﹤0.01% 900
2025
Q1 		$307K Buy
730
+70
+11% +$30.4K ﹤0.01% 916
2024
Q4 		$273K Buy
660
+112
+20% +$49.1K ﹤0.01% 848
2024
Q3 		$277K Sell
548
-7
-1% -$3.4K 0.01% 699
2024
Q2 		$271K Buy
555
+6
+1% +$3.01K 0.01% 689
2024
Q1 		$297K Buy
549
+129
+31% +$70.5K 0.01% 575
2023
Q4 		$233K Buy
+420
New +$197K 0.01% 396

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Waverly Advisors's IDXX Position: Q2 2026 in Review

Waverly Advisors reduced its Idexx Laboratories (IDXX) stake by 5.5% in Q2 2026, selling an estimated $97K and leaving 2,995 shares worth $1.58M. The position accounts for 0.01% of the portfolio, ranked #756.

Waverly Advisors first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.05M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Waverly Advisors held 2,995 shares of Idexx Laboratories worth $1.58M as of Q2 2026.
  • Waverly Advisors sold 173 Idexx Laboratories shares in Q2 2026, an estimated $97K.
  • Idexx Laboratories made up 0.01% of Waverly Advisors's portfolio in Q2 2026, its #756 holding.
  • Waverly Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Waverly Advisors's Idexx Laboratories position peaked at $2.05M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.